Neumora stockholders elect Gosebruch and Burow as Class I directors, ratify EY as auditor

Neumora Therapeutics, Inc.

Henry O. Gosebruch elected with 88,190,874 votes for, 2,313,739 withheld, and 12,544,469 broker non-votes.
Kristina Burow elected with 87,022,169 votes for, 3,482,444 withheld, and 12,544,469 broker non-votes.
Ratification of Ernst & Young as auditor for FY2024: 102,921,992 for, 123,868 against, 3,222 abstentions.
As of record date April 15, 2024, 159,452,584 shares were outstanding and entitled to vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.